Connect with us

Hi, what are you looking for?

Capital Business
Capital Business
Sanofi, the 11th largest pharmaceutical company in the world by stock market valuation, made an unsolicited all-cash $9.3 billion takeover offer for US drug firm Medivation/AFP-File

Manufacturing

France’s Sanofi ‘confident’ in $9.3bn US takeover bid

Sanofi, the 11th largest pharmaceutical company in the world by stock market valuation, made an unsolicited all-cash $9.3 billion takeover offer for US drug firm Medivation/AFP-File

Sanofi, the 11th largest pharmaceutical company in the world by stock market valuation, made an unsolicited all-cash $9.3 billion takeover offer for US drug firm Medivation/AFP-File

PARIS, France, Apr 29 – France’s biggest pharmaceutical group, Sanofi, said Friday it is confident it can convince shareholders in US rival Medivation, which makes a blockbuster prostate cancer drug, to accept its $9.3 billion (8.2-billion-euro) all-cash takeover bid.

Sanofi revealed its bid on Thursday after being frustrated by a lack of response from the American drugs maker two weeks after submitting an unsolicited offer of $52.50 a share in writing.

“We are confident that Medivation shareholders will ultimately share our strong belief that our offer at $52.50 will provide significant and immediate cash value,” Sanofi chief executive Olivier Brandicourt said on a conference call.

“We believe that it’s in everyone’s best interest to proceed on a friendly basis,” he told investors after Sanofi reported a 6.3-percent rise in net profits to 1.09 billion euros ($1.2 billion) in the first quarter of the year despite sales slipping 3.3 percent to 7.78 billion euros.

“We hope Medivation’s board will take this opportunity and we will be able to constructively engage.”

Medivation, which notably makes the pricey prostate cancer drug Xtandi, confirmed Thursday that it had received Sanofi’s April 15 offer.

The US group said it planned to discuss the non-binding bid from Sanofi in a board meeting the same day, the results of which have yet to be made public.

If the offer is accepted, it would be Sanofi’s biggest acquisition since it bought the US biotech group Genzyme in 2011 for more than $20 billion.

Click to comment
Advertisement

More on Capital Business

Executive Lifestyle

NAIROBI, Kenya, Mar 12 – The country’s super wealthy individuals are increasing their holding of bonds, gold and cash, a new report by Knight...

Ask Kirubi

NAIROBI, Kenya, Mar 9 – Businessman and industrialist Dr. Chris Kirubi has urged members of the public to exercise extreme caution when making any...

Ask Kirubi

NAIROBI, Kenya, Mar 24 – Businessman and industrialist Dr. Chris Kirubi is set to own half of Centum Investment Company PLC, following a go-ahead...

Ask Kirubi

It is without a doubt that the COVID-19 pandemic has caught the whole world by surprise. Although its full impact is yet to be...

Headlines

NAIROBI, Kenya, Mar 18 – Commercial Banks have been ordered to provide relief to borrowers on their personal loans, with loans eligible from March...

Kenya

NAIROBI, Kenya, Jun17 – Kenya’s tea leaves manufacturer Kericho Gold, has been awarded the Superbrands Seal by Superbrands East Africa for their quality variety...

Coronavirus

NAIROBI, Kenya, Apr 13 – As the local telecommunications industry gears up to roll out 5G networks in the country, the Communications Authority of...

Coronavirus

NAIROBI, Kenya, Mar 22 – Airtel Kenya is offering free internet access for students in order to enable continued learning at home in the...